Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2005

View Archived Issues

Hepatitis B virus responses maintained with long-term adefovir therapy

Good PK and safety profile reported for AMG-162 in healthy men

Etanercept reported to reduce bone resorption in psoriatic arthritis

New data on the potential of ferumoxytol as iron replacement therapy

Atheroprotective effects reported for AST-120 in chronic renal failure patients

GCS-100 induces apoptosis in B-cell malignancies

CpG-7909 increases response to first-line chemotherapy in advanced NSCLC

GSK: five vaccine launches in next five years

Organon and Cypress Bioscience partner in obstructive sleep apnea

Rapid enrollment in ragweed allergy study of AIC

Phase II study evaluates picoplatin for small cell lung cancer

Second phase II trial for Hematide in chronic kidney disease patients

Phase I trial for Hsp90 inhibitor IPI-504

rIL-7 studied in HIV in two new phase I studies

OxThera created to advance Q-Med's oxalate project

Positive antitumor efficacy for MMI-166 in a model of lung cancer

Gefitinib/rosiglitazone combination enhances antiproliferative effects in lung cancer cells

Enrollment completed in phase I/II study of smallpox vaccine candidate LC16m8

A novel ORL1 agonist demonstrates efficacy in a model of neuropathic pain

Solvay signs final purchase agreement for Fournier

Arixtra approved in E.U. for prevention of VTE events in abdominal surgery

CE Mark approval for Axxion drug-eluting stent

Fast track status for Fluviral

Drug discovery targets for diabetes

HIV replication inhibitors from Janssen

Cysteine protease inhibitors in early development at Celera

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...